Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 10/20 | 0.61 |
| ▸ | NPC1 | O15118 | 10/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | AR | P10275 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.60 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.60 |
| ▸ | RELA | Q04206 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 7/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | TP53 | P04637 | 2/20 | 0.59 |
| ▸ | PKM | P14618 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | GMNN | O75496 | 1/20 | 0.59 |
| ▸ | THPO | P40225 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12112870 | 0.84 | RAB9A (0.80) | RAB9ANPC1MEN1KMT2AAR | |
| SCHEMBL7004636 | 0.84 | RAB9A (0.51) | RAB9ANPC1MEN1KMT2AAR | |
| SCHEMBL6082932 | 0.82 | KDM4E (0.50) | RAB9ANPC1MEN1KMT2AAR | |
| SCHEMBL29943655 | 0.82 | RAB9A (0.61) | RAB9ANPC1MEN1KMT2AAR | |
| SCHEMBL16484521 | 0.82 | RAB9A (0.61) | RAB9ANPC1MEN1KMT2AAR | |
| SCHEMBL61467 | 0.81 | NPC1 (0.56) | RAB9ANPC1MEN1KMT2AAR | |
| SCHEMBL6013594 | 0.79 | NPC1 (0.67) | RAB9ANPC1MEN1KMT2AAR | |
| SCHEMBL12402694 | 0.79 | MAOA (0.56) | KDM4EALDH1A1CYP1A2APPMAOA | |
| SCHEMBL6084045 | 0.79 | APP (0.50) | KDM4EALDH1A1CYP1A2APPMAOA | |
| SCHEMBL12249737 | 0.79 | NPC1 (0.53) | RAB9ANPC1MEN1KMT2AAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10254646-B2 | Composition sensitive to radiation in electromagnetic spectrum ranges for printing purposes, printing plate comprising said composition, use of said composition and image development process | IBF INDUSTRIA BRASILEIRA DE FILMES S/A (BR) | 2019-04-09 | — | — | US | claimed |
| US-20160026080-A1 | COMPOSITION SENSITIVE TO RADIATION IN ELECTROMAGNETIC SPECTRUM RANGES FOR PRINTING PURPOSES, PRINTING PLATE COMPRISING SAID COMPOSITION, USE OF SAID COMPOSITION AND IMAGE DEVLOPMENT PROCESS | IBF INDUSTRIA BRASILEIRA DE FILMES S/A (BR) | 2016-01-28 | — | — | US | claimed |
| EP-2937733-A1 | COMPOSITION SENSITIVE TO RADIATION IN ELECTROMAGNETIC SPECTRUM RANGES FOR PRINTING PURPOSES, PRINTING PLATE COMPRISING SAID COMPOSITION, USE OF SAID COMPOSITION AND IMAGE DEVELOPMENT PROCESS | IBF - Indústria Brasileira de Filmes S/A (BR) | 2015-10-28 | — | — | EP | claimed |
| EP-2640703-A1 | HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY | GE Healthcare UK Limited (GB) | 2013-09-25 | — | — | EP | claimed |
| US-20130236395-A1 | HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY | GE HEALTHCARE LIMITED (GB) | 2013-09-12 | — | — | US | claimed |
| CN-103298789-A | Heterocyclic compounds as imaging probes of tau pathology | GE HEALTHCARE LTD | 2013-09-11 | — | — | CN | claimed |
| WO-2012067863-A1 | HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY | GE HEALTHCARE LIMITED (GB) | 2012-05-24 | — | — | WO | claimed |
| US-7118730-B2 | Quinoline derivative as diagnostic probe for disease with tau protein accumulation | BF RESEARCH INSTITUTE, INC. (JP) | 2006-10-10 | — | — | US | claimed |
| EP-4257623-B1 | PHOTOSENSITIVE POLYIMIDE RESIN COMPOSITION, RESIN FILM, AND ELECTRONIC DEVICE | MITSUBISHI GAS CHEMICAL CO (JP) | 2026-05-27 | — | — | EP | disclosed |
| CN-122029488-A | Photosensitive coloring composition, cured product, partition wall, organic electroluminescent element, color filter, and image display device | 三菱化学株式会社 | 2026-05-12 | — | — | CN | disclosed |
| US-12441842-B2 | Polyimide resin, photosensitive resin composition, resin film, and electronic device | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-10-14 | — | — | US | disclosed |
| CN-120029007-A | Colored photosensitive resin composition, partition wall, organic electroluminescent element, image display device, and illumination | 三菱化学株式会社 | 2025-05-23 | — | — | CN | disclosed |
| CN-112313579-B | Photosensitive colored resin composition, cured product, image display device, and illumination | 三菱化学株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-119948406-A | Photosensitive colored resin composition, cured product, partition wall, organic electroluminescent element, color filter, and image display device | 三菱化学株式会社 | 2025-05-06 | — | — | CN | disclosed |
| US-6048653-A | (METH)ACRYLATE COPOLYMER WITH ALICYCLIC(METH)ACRYLOYL GROUP ON THE SIDE CHAIN AND AN UNSATURATED DOUBLE BOND A PHOTOPOLYMERIZABLE INITIATOR AND COLORANT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2000-04-11 | — | — | US | disclosed |
| US-5916713-A | CONTAINING A (METH)ACRYLATE COPOLYMER | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-06-29 | — | — | US | disclosed |
| EP-0758097-A1 | POLYMERIZABLE COMPOSITION FOR COLOR FILTER | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-02-12 | — | — | EP | disclosed |
| EP-0138187-B1 | PHOTOPOLYMERIZABLE COMPOSITION | MITSUBISHI KASEI CORPORATION (JP) | 1989-01-11 | — | — | EP | disclosed |
| US-4594310-A | Photopolymerizable composition comprising tertiary aromatic amine and hexaarylbiimazole initiators | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) | 1986-06-10 | — | — | US | disclosed |
| EP-0138187-A2 | Photopolymerizable composition | MITSUBISHI KASEI CORPORATION (JP) | 1985-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130236395-A1 | HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY | MAPT, PSEN1, PSEN2 | RAB9A 1703/4885NPC1 127/4885MEN1 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.